Vmn1r194 is a gene that belongs to the vomeronasal 1 receptor (V1R) family, a group of genes typically involved in pheromone detection and social behaviors in animals. These receptors are primarily expressed in the vomeronasal organ (VNO), a part of the olfactory system dedicated to detecting pheromones and other chemical signals that influence social and reproductive behaviors. The specific role of Vmn1r194 in sensory perception, especially in relation to pheromone detection and processing, is crucial in understanding its biological significance. The inhibition of Vmn1r194 is an intricate process, as it involves modulating the various signaling pathways and molecular interactions that regulate its expression and function. The inhibitors selected target multiple pathways that are potentially involved in the regulation of Vmn1r194. These pathways include the MAP kinase pathways (p38, JNK, ERK), the PI3K/Akt pathway, and other signaling mechanisms related to stress, inflammation, and cellular metabolism. Inhibitors like SB203580, PD98059, and SP600125, which target the MAP kinase pathways, are crucial as these pathways are often involved in the transduction of environmental stimuli into cellular responses. By modulating these pathways, these inhibitors could potentially alter the expression or function of Vmn1r194, particularly if the gene is responsive to environmental or stress-related signals.
PI3K/Akt pathway inhibitors such as LY294002 and Wortmannin play a role in a wide range of cellular processes, including cell growth, survival, and metabolism. Given the broad role of this pathway, its inhibition could have downstream effects on the expression of Vmn1r194, especially if the gene is involved in cellular responses regulated by this pathway. Other inhibitors, such as Dorsomorphin, Rapamycin, and Bafilomycin A1, target different aspects of cellular function, such as energy metabolism, cell growth, and lysosomal function. The indirect influence of these inhibitors on Vmn1r194 highlights the complexity of the gene's regulation, as it may be influenced by various cellular states and metabolic conditions. Lastly, inhibitors like Genistein, Curcumin, and Resveratrol provide insights into the potential role of Vmn1r194 in processes modulated by tyrosine kinases, inflammatory pathways, and epigenetic mechanisms. These inhibitors demonstrate the diverse ways in which Vmn1r194 can be modulated, reflecting the multifaceted nature of its regulation in the context of sensory perception and pheromone detection. Overall, the exploration of Vmn1r194 inhibition is not just about understanding the regulation of a single gene but delving into the complex network of signaling pathways and molecular interactions that govern sensory perception and pheromone detection in animals. The inhibitors identified offer a glimpse into the potential mechanisms through which Vmn1r194 can be modulated, providing a foundation for further studies into the role of this gene in sensory biology and animal behavior.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor, known to interfere with inflammatory cytokine production. Inhibiting p38 MAP kinase might reduce Vmn1r194 expression by attenuating the signaling pathways that upregulate its expression in response to inflammatory stimuli. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, impedes the PI3K/Akt pathway, crucial in many cellular processes. This inhibition may indirectly suppress Vmn1r194 by disrupting the signaling that regulates its expression in neuronal or sensory cells. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, disrupts the MAPK/ERK pathway. This action can potentially downregulate Vmn1r194 expression by interfering with signaling pathways involved in sensory processing or neuronal activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, targets the JNK pathway, affecting stress and inflammatory responses. By inhibiting JNK signaling, SP600125 might indirectly suppress Vmn1r194 expression, assuming the gene is regulated by stress or inflammatory signals. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, another MEK inhibitor, particularly targets the ERK pathway. This inhibition may lead to a reduction in Vmn1r194 expression, if the gene is part of a cellular response mediated by the ERK pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a potent PI3K inhibitor, can disrupt multiple signaling pathways, including those regulating sensory perception. This broad inhibition could lead to a decrease in Vmn1r194 expression if it is regulated by PI3K-dependent pathways. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
BML-275, an AMPK inhibitor, may influence cellular energy metabolism. By altering AMPK activity, dorsomorphin could indirectly affect Vmn1r194 expression, particularly in energy-responsive cellular contexts. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, known for inhibiting mTOR, affects cell growth and proliferation. Inhibiting mTOR might lead to decreased Vmn1r194 expression, especially if the gene is involved in cell growth-related pathways. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1, a specific inhibitor of the vacuolar-type H+-ATPase, can disrupt lysosomal acidification. This disruption might indirectly reduce Vmn1r194 expression if the gene plays a role in processes influenced by lysosomal function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, may impact cellular signaling pathways including those in sensory or neuronal cells. This could lead to indirect suppression of Vmn1r194 if its expression is regulated by tyrosine kinase-dependent pathways. | ||||||